ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,584Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 939

$1.06M Total Retail Price of All Prescriptions

Rank: 38 out of 939

389 Patients Receiving at Least One Drug in Part D
36%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 389 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

54% of this provider’s 389 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 6,118 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,307 456 S3 1 1
LISINOPRIL 748 218 2 3
AMLODIPINE BESYLATE 721 339 3 6
NEXIUM 656 151 4 18
FUROSEMIDE 447 233 5 7
METFORMIN HCL 439 154 6 8
CITALOPRAM HBR 401 188 7 15
GABAPENTIN 394 104 8 11
OMEPRAZOLE 375 150 9 5
LEVOTHYROXINE SODIUM 250 93 10 4
SIMVASTATIN 247 80 11 2
MELOXICAM 240 114 12 14
POTASSIUM CHLORIDE 234 108 13 9
CRESTOR 228 136 14 34
HYDROCHLOROTHIAZIDE 215 86 15 12
ATORVASTATIN CALCIUM 213 70 16 22
ZOLPIDEM TARTRATE 208 81 17 20
GLIPIZIDE ER 206 90 18 88
SUCRALFATE 191 57 19 96
CLOPIDOGREL 187 83 20 28
PROAIR HFA 187 41 20 41
CARISOPRODOL 184 15 R 22 51
AZITHROMYCIN 171 39 23 32
TRAMADOL HCL 153 51 24 16
VENTOLIN HFA 152 50 25 80
LANTUS 150 25 26 59
SYMBICORT 149 43 27 137
TIZANIDINE HCL 148 57 28 81
OXYCODONE HCL-ACETAMINOPHEN 145 40 S2 29 107
CYMBALTA 144 38 30 44
PROMETHAZINE HCL 137 43 R 31 68
SERTRALINE HCL 132 46 32 24
GLIPIZIDE 132 68 32 52
SINGULAIR 125 42 34 101
DIOVAN 123 70 35 50
ISOSORBIDE MONONITRATE ER 122 62 36 53
XOPENEX HFA 122 37 36 245
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 33 38 23
PLAVIX 119 66 38 48
PRAVASTATIN SODIUM 111 38 40 13
FLUTICASONE PROPIONATE 102 39 41 43
METOPROLOL TARTRATE 102 54 41 10
AMITRIPTYLINE HCL 102 27 R 41 38
CARVEDILOL 99 41 44 25
COMBIVENT 96 16 45 120
TRAZODONE HCL 95 26 46 26
PANTOPRAZOLE SODIUM 94 32 47 66
MONTELUKAST SODIUM 90 28 48 172
WARFARIN SODIUM 90 51 48 17
MORPHINE SULFATE ER 90 25 S2 48 113
LEVOFLOXACIN 89 36 51 86
AMOXICILLIN 87 28 52 92
RANITIDINE HCL 86 0 53 35
NASONEX 85 19 54 247
ENDOCET 84 0 S2 55 148
ESCITALOPRAM OXALATE 83 27 56 61
METOCLOPRAMIDE HCL 82 40 57 119
INSULIN SYRINGE 81 12 58 97
HYDROXYZINE PAMOATE 76 0 R 59 220
LANTUS SOLOSTAR 76 21 59 128
CYCLOBENZAPRINE HCL 75 0 R 61 36
FLUOXETINE HCL 72 16 62 47
CELEBREX 71 34 63 106
CLONIDINE HCL 69 46 64 39
ATENOLOL 68 0 65 19
OXYCONTIN 68 24 S2 65 161
SPIRIVA 66 0 67 73
METOPROLOL SUCCINATE 63 44 68 21
DIGOXIN 63 39 68 45
TOPIRAMATE 62 0 70 154
TAMSULOSIN HCL 62 36 70 27
ROPINIROLE HCL 62 13 70 78
LYRICA 59 30 73 63
ZETIA 58 0 74 103
KLOR-CON M20 56 39 75 90
METHYLPREDNISOLONE 55 14 76 118
DONEPEZIL HCL 55 51 76 30
GLYBURIDE 55 0 R 76 89
CIPROFLOXACIN HCL 55 0 76 54
LANSOPRAZOLE 54 22 80 177
AMLODIPINE BESYLATE-BENAZEPRIL 54 47 80 58
NOVOLOG 54 0 80 145
RAMIPRIL 53 0 83 91
DIOVAN HCT 53 29 83 74
ALLOPURINOL 52 18 85 31
PREMARIN 52 12 R 85 111
LIPITOR 50 26 87 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.